| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
KK Yoshida Jimusho
|
20.100m | 40.83% | — | Sep 30 2025 |
| 2 |
Sumitomo Mitsui DS Asset Management Company, Limited
|
2.653m | 5.39% | +2.606m | Jan 30 2026 |
| 3 |
Brown Capital Management, LLC
|
1.921m | 3.90% | -479.600k | Mar 31 2026 |
| 4 |
Towa Pharmaceutical Company Ltd. Kyoeikai Association
|
1.530m | 3.11% | -6.000k | Sep 30 2025 |
| 5 |
Yoshida (Itsuro)
|
1.455m | 2.96% | — | Sep 30 2025 |
|
1
KK Yoshida Jimusho
|
40.83%
20.100m
|
|
2
Sumitomo Mitsui DS Asset Management Company, Limited
|
5.39%
2.653m
|
|
3
Brown Capital Management, LLC
|
3.90%
1.921m
|
|
4
Towa Pharmaceutical Company Ltd. Kyoeikai Association
|
3.11%
1.530m
|
|
5
Yoshida (Itsuro)
|
2.96%
1.455m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 56.18% of Towa Pharmaceutical Co, with KK Yoshida Jimusho the biggest at 40.83%, followed by Sumitomo Mitsui DS Asset Management Company, Limited (5.39%) and Brown Capital Management, LLC (3.90%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


